Esperion Therapeutics Inc (ESPR)
1.99
-0.14
(-6.57%)
USD |
NASDAQ |
Apr 25, 16:00
2.01
+0.02
(+1.01%)
After-Hours: 20:00
Esperion Therapeutics Total Liabilities (Quarterly): 660.79M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 660.79M |
| September 30, 2023 | 631.31M |
| June 30, 2023 | 606.60M |
| March 31, 2023 | 581.48M |
| December 31, 2022 | 571.72M |
| September 30, 2022 | 606.93M |
| June 30, 2022 | 595.68M |
| March 31, 2022 | 591.89M |
| December 31, 2021 | 578.53M |
| September 30, 2021 | 587.96M |
| June 30, 2021 | 584.77M |
| March 31, 2021 | 548.00M |
| December 31, 2020 | 449.39M |
| September 30, 2020 | 242.01M |
| June 30, 2020 | 244.86M |
| March 31, 2020 | 229.89M |
| December 31, 2019 | 194.50M |
| September 30, 2019 | 186.76M |
| June 30, 2019 | 179.48M |
| March 31, 2019 | 61.47M |
| December 31, 2018 | 64.33M |
| September 30, 2018 | 42.28M |
| June 30, 2018 | 34.96M |
| Date | Value |
|---|---|
| March 31, 2018 | 30.05M |
| December 31, 2017 | 33.14M |
| September 30, 2017 | 35.00M |
| June 30, 2017 | 31.14M |
| March 31, 2017 | 22.19M |
| December 31, 2016 | 16.61M |
| September 30, 2016 | 9.611M |
| June 30, 2016 | 9.506M |
| March 31, 2016 | 8.276M |
| December 31, 2015 | 8.313M |
| September 30, 2015 | 9.912M |
| June 30, 2015 | 10.50M |
| March 31, 2015 | 10.79M |
| December 31, 2014 | 9.722M |
| September 30, 2014 | 10.31M |
| June 30, 2014 | 10.38M |
| March 31, 2014 | 3.188M |
| December 31, 2013 | 4.203M |
| September 30, 2013 | 3.343M |
| June 30, 2013 | 6.644M |
| March 31, 2013 | 2.521M |
| December 31, 2012 | 24.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
179.48M
Minimum
Jun 2019
660.79M
Maximum
Dec 2023
466.98M
Average
578.53M
Median
Dec 2021
Total Liabilities (Quarterly) Benchmarks
| United Therapeutics Corp | 1.182B |
| Masimo Corp | 1.677B |
| Heron Therapeutics Inc | 256.48M |
| Aldeyra Therapeutics Inc | 28.53M |
| Ocugen Inc | 23.98M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 205.80M |
| Shareholders Equity (Quarterly) | -454.99M |
| Debt to Equity Ratio | -0.5749 |
| Current Ratio | 1.287 |
| Net Debt Paydown Yield | -0.12% |